In a healthy eye, a clear fluid called aqueous humor is continuously produced and drained through a specialized drainage structure known as the iridocorneal angle. This fluid maintains normal eye pressure and provides nutrients to internal eye tissues. In dogs affected by POAG-3, genetic mutations impair the function of the drainage system, causing fluid to accumulate gradually. As intraocular pressure increases, it places stress on the optic nerve, which is responsible for transmitting visual information from the eye to the brain.
Clinical signs of Primary Open Angle Glaucoma often develop slowly and may be difficult to detect in the early stages. Initial symptoms may include mild eye discomfort, increased blinking, redness, or excessive tearing. As pressure builds, affected dogs may develop corneal cloudiness, pupil dilation, reduced vision, and behavioral changes such as reluctance to navigate unfamiliar environments or bumping into objects. In advanced stages, the eye may become enlarged (buphthalmos), and permanent blindness can occur due to irreversible optic nerve damage.
The POAG-3 DNA Health Test is designed to detect the specific genetic mutation associated with this form of glaucoma. Testing is simple, safe, and non-invasive, typically requiring a cheek swab or blood sample. The sample is analyzed in a specialized laboratory to determine the dog’s genetic status. Since DNA remains unchanged throughout life, testing can be performed at any age, including before clinical signs appear.
Results are generally reported in three categories:
- Clear (Normal): The dog does not carry the POAG-3 mutation and is not expected to develop this genetic form of glaucoma or pass it to offspring.
- Carrier: The dog carries one copy of the mutation but may not show clinical signs. However, it can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and has a significantly increased likelihood of developing Primary Open Angle Glaucoma (POAG-3).
Genetic testing for POAG-3 is highly valuable for breeders, veterinarians, and dog owners. Breeders can use results to make informed breeding decisions that reduce the prevalence of glaucoma while preserving healthy genetic diversity within the breed population. Avoiding carrier-to-carrier pairings significantly reduces the risk of producing affected puppies.
For dog owners, knowing a dog’s genetic status allows for proactive eye health monitoring and early veterinary evaluation. Dogs identified as at risk should undergo regular ophthalmic examinations to detect early increases in intraocular pressure. While there is currently no cure for glaucoma-related optic nerve damage, early diagnosis and treatment—such as pressure-lowering medications or surgical intervention—can help slow progression and preserve vision for as long as possible.
The Primary Open Angle Glaucoma (POAG-3) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine ocular health, and helps reduce the impact of this inherited cause of blindness in future generations.
